Search Results - "GARDINER, ROBERT A"

Robot-assisted laparoscopic prostatectomy versus open radical retropubic prostatectomy: early outcomes from a randomised controlled phase 3 study by Yaxley, John W, FRACS, Coughlin, Geoffrey D, FRACS, Chambers, Suzanne K, Prof, Occhipinti, Stefano, PhD, Samaratunga, Hema, FRCPA, Zajdlewicz, Leah, MOrgPsych, Dunglison, Nigel, FRACS, Carter, Rob, Prof, Williams, Scott, MBBS, Payton, Diane J, FRCPA, Perry-Keene, Joanna, FRCPA, Lavin, Martin F, Prof, Gardiner, Robert A, Prof

“…Summary Background The absence of trial data comparing robot-assisted laparoscopic prostatectomy and open radical retropubic prostatectomy is a crucial…”
Get full text

Epigenetically reprogrammed methylation landscape drives the DNA self-assembly and serves as a universal cancer biomarker by Sina, Abu Ali Ibn, Carrascosa, Laura G., Liang, Ziyu, Grewal, Yadveer S., Wardiana, Andri, Shiddiky, Muhammad J. A., Gardiner, Robert A., Samaratunga, Hemamali, Gandhi, Maher K., Scott, Rodney J., Korbie, Darren, Trau, Matt

“…Epigenetic reprogramming in cancer genomes creates a distinct methylation landscape encompassing clustered methylation at regulatory regions separated by large…”
Get full text

Mindfulness-Based Cognitive Therapy in Advanced Prostate Cancer: A Randomized Controlled Trial by Chambers, Suzanne K, Occhipinti, Stefano, Foley, Elizabeth, Clutton, Samantha, Legg, Melissa, Berry, Martin, Stockler, Martin R, Frydenberg, Mark, Gardiner, Robert A, Lepore, Stephen J, Davis, Ian D, Smith, David P

“…Purpose Advanced prostate cancer (PC) is associated with substantial psychosocial morbidity. We sought to determine whether mindfulness-based cognitive therapy…”
Get full text

Clinical significance of the LacdiNAc‐glycosylated prostate‐specific antigen assay for prostate cancer detection by Yoneyama, Tohru, Tobisawa, Yuki, Kaneko, Tomonori, Kaya, Takatoshi, Hatakeyama, Shingo, Mori, Kazuyuki, Sutoh Yoneyama, Mihoko, Okubo, Teppei, Mitsuzuka, Koji, Duivenvoorden, Wilhelmina, Pinthus, Jehonathan H., Hashimoto, Yasuhiro, Ito, Akihiro, Koie, Takuya, Suda, Yoshihiko, Gardiner, Robert A., Ohyama, Chikara

“…To reduce unnecessary prostate biopsies (Pbx), better discrimination is needed. To identify clinically significant prostate cancer (CSPC) we determined the…”
Get full text

Epidemiology of prostate cancer in the Asia-Pacific region by Baade, Peter D., Youlden, Danny R., Cramb, Susanna M., Dunn, Jeff, Gardiner, Robert A.

“…The purpose of this paper was to examine and compare available data on incidence, mortality and survival for countries in the Asia-Pacific region. Incidence…”
Get full text

Urban-rural differences in prostate cancer outcomes in Australia: what has changed? by Baade, Peter D, Youlden, Danny R, Coory, Michael D, Gardiner, Robert A, Chambers, Suzanne K

“…Objective: To update our previous analysis of trends for prostate‐specific antigen (PSA) testing, prostate cancer incidence, radical prostatectomy and prostate…”
Get full text

New genomic structure for prostate cancer specific gene PCA3 within BMCC1: implications for prostate cancer detection and progression by Clarke, Raymond A, Zhao, Zhongming, Guo, An-Yuan, Roper, Kathrein, Teng, Linda, Fang, Zhi-Ming, Samaratunga, Hema, Lavin, Martin F, Gardiner, Robert A

“…The prostate cancer antigen 3 (PCA3/DD3) gene is a highly specific biomarker upregulated in prostate cancer (PCa). In order to understand the importance of…”
Get full text

Potential Role of Exercise Induced Extracellular Vesicles in Prostate Cancer Suppression by Zhang, Ying, Kim, Jin-Soo, Wang, Tian-Zhen, Newton, Robert U., Galvão, Daniel A., Gardiner, Robert A., Hill, Michelle M., Taaffe, Dennis R.

“…Physical exercise is increasingly recognized as a valuable treatment strategy in managing prostate cancer, not only enhancing supportive care but potentially…”
Get full text

Caveolin‐1‐driven membrane remodelling regulates hnRNPK‐mediated exosomal microRNA sorting in cancer by Robinson, Harley, Ruelcke, Jayde E., Lewis, Amanda, Bond, Charles S., Fox, Archa H., Bharti, Vandhana, Wani, Shivangi, Cloonan, Nicole, Lai, Andrew, Margolin, David, Li, Li, Salomon, Carlos, Richards, Renée S., Farrell, Aine, Gardiner, Robert A., Parton, Robert G., Cristino, Alexandre S., Hill, Michelle M.

“…Background Caveolae proteins play diverse roles in cancer development and progression. In prostate cancer, non‐caveolar caveolin‐1 (CAV1) promotes metastasis,…”
Get full text

BMCC1 is an AP-2 associated endosomal protein in prostate cancer cells by Harris, Janelle L, Richards, Renée S, Chow, Clement W K, Lee, Soon, Kim, Misook, Buck, Marion, Teng, Linda, Clarke, Raymond, Gardiner, Robert A, Lavin, Martin F

“…The prostate cancer antigen gene 3 (PCA3) is embedded in an intron of a second gene BMCC1 (Bcl2-/adenovirus E1B nineteen kDa-interacting protein 2 (BNIP-2) and…”
Get full text

Robot-assisted laparoscopic prostatectomy versus open radical retropubic prostatectomy: 24-month outcomes from a randomised controlled study by Coughlin, Geoffrey D, Yaxley, John W, Chambers, Suzanne K, Occhipinti, Stefano, Samaratunga, Hema, Zajdlewicz, Leah, Teloken, Patrick, Dunglison, Nigel, Williams, Scott, Lavin, Martin F, Gardiner, Robert A

“…Previous trials have found similar early outcomes after robot-assisted laparoscopic prostatectomy and open radical retropubic prostatectomy. We report…”
Get full text

Integrating disparate snippets of information in an approach to PSA testing in Australia and New Zealand by Gardiner, Robert (‘Frank’) A., Yaxley, John, Baade, Peter D.

“…An invited response to ‘Stricker PD, Frydenberg M, Kneebone A, Chopra S. Informed prostate cancer risk‐adjusted testing: a new paradigm’…”
Get full text

Seminal plasma enables selection and monitoring of active surveillance candidates using nuclear magnetic resonance-based metabolomics: A preliminary investigation by Roberts, Matthew J., Richards, Renee S., Chow, Clement W.K., Buck, Marion, Yaxley, John, Lavin, Martin F., Schirra, Horst Joachim, Gardiner, Robert A.

“…Diagnosis and monitoring of localized prostate cancer requires discovery and validation of noninvasive biomarkers. Nuclear magnetic resonance (NMR)-based…”
Get full text

Use of multiple biomarkers for a molecular diagnosis of prostate cancer by Landers, Kelly A., Burger, Michelle J., Tebay, Michelle A., Purdie, David M., Scells, Betty, Samaratunga, Hemamali, Lavin, Martin F., Gardiner, Robert A.

“…The identification of biomarkers capable of providing a reliable molecular diagnostic test for prostate cancer (PCa) is highly desirable clinically. We…”
Get full text

Genetic association of the KLK4 locus with risk of prostate cancer by Lose, Felicity, Srinivasan, Srilakshmi, O'Mara, Tracy, Marquart, Louise, Chambers, Suzanne, Gardiner, Robert A, Aitken, Joanne F, Spurdle, Amanda B, Batra, Jyotsna, Clements, Judith A

“…The Kallikrein-related peptidase, KLK4, has been shown to be significantly overexpressed in prostate tumours in numerous studies and is suggested to be a…”
Get full text

Defining young in the context of prostate cancer by Chambers, Suzanne K, Lowe, Anthony, Hyde, Melissa K, Zajdlewicz, Leah, Gardiner, Robert A, Sandoe, David, Dunn, Jeff

“…The experience of prostate cancer is for most men a major life stress with the psychological burden of this disease falling more heavily on those who are…”
Get full text

A randomised trial of robotic and open prostatectomy in men with localised prostate cancer by Gardiner, Robert A, Yaxley, John, Coughlin, Geoff, Dunglison, Nigel, Occhipinti, Stefano, Younie, Sandra, Carter, Rob, Williams, Scott, Medcraft, Robyn J, Bennett, Nigel, Lavin, Martin F, Chambers, Suzanne Kathleen

“…Prostate cancer is the most common male cancer in the Western world however there is ongoing debate about the optimal treatment strategy for localised disease…”
Get full text

PSA testing for men at average risk of prostate cancer by Armstrong, Bruce K, Barry, Michael J, Frydenberg, Mark, Gardiner, Robert A, Haines, Ian, Carter, Stacy M

“…Prostate-specific antigen (PSA) testing of men at normal risk of prostate cancer is one of the most contested issues in cancer screening. There is no formal…”
Get full text

Common variation in Kallikrein genes KLK5 , KLK6 , KLK12 , and KLK13 and risk of prostate cancer and tumor aggressiveness by Lose, Felicity, Ph.D, Batra, Jyotsna, Ph.D, O'Mara, Tracy, B.Sc.(Hons), Fahey, Paul, Ph.D, Marquart, Louise, B.Econ., B.Sc., B.App.Sc.(Hons), Eeles, Ros A., M.A., Ph.D., F.R.C.P., F.R.C.R, Easton, Douglas F., Ph.D, Al Olama, Ali Amin, Ph.D, Kote-Jarai, Zsofia, Ph.D, Guy, Michelle, Ph.D, Muir, Kenneth, Ph.D, Lophatananon, Artitaya, Ph.D, Rahman, Aneela A., Ph.D, Neal, David E., M.S., F.R.C.S, Hamdy, Freddie C., M.D., F.R.C.S, Donovan, Jenny L., Ph.D, Chambers, Suzanne, Ph.D, Gardiner, Robert A., M.D., F.R.C.S., F.R.A.C.S, Aitken, Joanne F., Ph.D, Yaxley, John, M.D., F.R.A.C.S, Alexander, Kimberly, Ph.D, Clements, Judith A., Ph.D, Spurdle, Amanda B., Ph.D, Kedda, Mary-Anne, Ph.D

“…Abstract The human tissue Kallikrein family consists of 15 genes with the majority shown to be differentially expressed in cancers and/or indicators of cancer…”
Get full text

A phase III clinical trial of exercise modalities on treatment side-effects in men receiving therapy for prostate cancer by Newton, Robert U, Taaffe, Dennis R, Spry, Nigel, Gardiner, Robert A, Levin, Gregory, Wall, Bradley, Joseph, David, Chambers, Suzanne K, Galvão, Daniel A

“…Androgen deprivation therapy (ADT) is accompanied by a number of adverse side effects including reduced bone mass and increased risk for fracture, reduced lean…”
Get full text